Maryland Oncology

Maryland Oncology Hematology (MOH) is a leading independent oncology and hematology practice providing comprehensive cancer care and clinical research services throughout Maryland and the Washington, D.C. area. Founded in 1986, the practice has grown to include over 55 physicians practicing across 18 locations, offering specialized services in medical, radiation, and surgical oncology. As a member of The US Oncology Network, MOH integrates evidence-based medicine with personalized care, providing patients access to advanced treatment modalities such as immunotherapy and targeted therapies. The organization maintains a robust clinical research program in partnership with the Sarah Cannon Research Institute, offering patients access to Phase I through Phase IV clinical trials. MOH is dedicated to community-based care, ensuring that patients receive high-quality, state-of-the-art treatment in a compassionate environment close to home.